Document Detail


Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus.
MedLine Citation:
PMID:  8851169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In an effort to evaluate the feasibility of kappa-opioid receptor agonists for use in pregnancy, we have investigated the actions of U50,488H (trans-3,4-dichloro-N-methyl-N-[2-(1- pyrrolidinyl)cyclohexyl]benzeneacetamide) on cardiovascular and respiratory control in the unanaesthetized ovine foetus. Intravenous administration of U50,488H (1.0 mg/kg) to the foetus resulted in an immediate increase in foetal blood pressure (P < 0.0001) and heart rate (P < 0.0001) which lasted 15 min, followed by a prolonged loss of heart rate variability for up to 3 h. There was also a significant suppression of foetal breathing movements for 2-3 h (P < 0.008). Pretreatment with naloxone (12 mg/h) completely blocked the hypertensive and tachycardiac response to U50,488H, but was unable to prevent the loss of variation in heart rate or respiratory depression. These data suggest that U50,488H can exert direct cardiovascular and respiratory actions in the ovine foetus via both opioid and non-opioid mechanisms. The naloxone-insensitive suppression of foetal breathing would severely limit the use of U50,488H as an obstetrical analgesic.
Authors:
H H Szeto; D Wu; P Y Cheng; Y Soong; C C Taylor; J Yee
Related Documents :
7792119 - Validation of the phase angle technique as an objective measure of upper airway obstruc...
22316729 - An approach to aircraft seat comfort using interface pressure mapping.
12401119 - Dissociation between respiratory effort and dyspnoea in a subset of patients with stroke.
15778489 - Fluctuations in end-expiratory lung volume during cheyne-stokes respiration.
1541129 - Spontaneous breathing and total body oxygen consumption in children recovering from ope...
14608459 - Extubation failure: diagnostic value of occlusion pressure (p0.1) and p0.1-derived para...
7652109 - Form and magnitude of beta-sympathetic and parasympathetic influences on pulse transit ...
6204139 - Endocrine control of salt and water excretion: the role of vasopressin in doca-salt hyp...
2311669 - Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  European journal of pharmacology     Volume:  297     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1996 Feb 
Date Detail:
Created Date:  1996-12-05     Completed Date:  1996-12-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  77-82     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Cornell University Medical College, New York, NY 10021, USA. hhszeto@mail.med.cornell.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
Animals
Antihypertensive Agents / pharmacology*
Blood Gas Analysis
Blood Pressure / drug effects
Female
Fetus / physiology*
Heart Rate, Fetal / drug effects
Hemodynamics / drug effects*
Naloxone / antagonists & inhibitors,  pharmacology
Narcotic Antagonists / pharmacology
Pregnancy
Pyrrolidines / pharmacology*
Respiratory Mechanics / drug effects*
Sheep
Grant Support
ID/Acronym/Agency:
02475-16//PHS HHS; 08924-01//PHS HHS; DA07274-04/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Narcotic Antagonists; 0/Pyrrolidines; 465-65-6/Naloxone; 67198-13-4/3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary cholesterol enhances impaired endothelium-dependent relaxations in aortas of salt-induced hy...
Next Document:  SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.